With these additions, GVN strengthens its presence across the Americas and advances global capacity to address viral threats ranging from HIV and arboviruses to emerging pathogens and future pandemic ...
For cancer patients, administration of a COVID-19 vaccine within 100 days of ICI initiation was associated with increased overall survival.